| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | 0.0084 | 0.8 |
| mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | 0.0078 | 0.8 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.0082 | 0.8 |
| mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | -0.008 | 0.8 |
| mRNA | TGX221 | GDSC1000 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | 0.0067 | 0.8 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | 0.0076 | 0.8 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0082 | 0.8 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | 0.008 | 0.8 |